AstraZeneca presented US with OUTDATED and CHERRY-PICKED vaccine trial data, concludes independent monitoring board

(Natural News) AstraZeneca may have cherry-picked its data and included “outdated” information when the company published the results of its U.S. trial for its Wuhan coronavirus (COVID-19) vaccine. This is according to independent experts monitoring the pharmaceutical company’s work. AstraZeneca has been enduring months of public criticism over the effectiveness and safety of its coronavirus vaccine....